These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9834080

  • 21. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis.
    Hashim GA, Vandenbark AA, Galang AB, Diamanduros T, Carvalho E, Srinivasan J, Jones R, Vainiene M, Morrison WJ, Offner H.
    J Immunol; 1990 Jun 15; 144(12):4621-7. PubMed ID: 1693637
    [Abstract] [Full Text] [Related]

  • 22. Encephalitogenic T cell clones with variant receptor specificity.
    Offner H, Hashim GA, Chou YK, Celnik B, Jones R, Vandenbark AA.
    J Immunol; 1988 Dec 01; 141(11):3828-32. PubMed ID: 2460551
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
    Nag B, Kendrick T, Arimilli S, Yu SC, Sriram S.
    Cell Immunol; 1996 May 25; 170(1):25-33. PubMed ID: 8660796
    [Abstract] [Full Text] [Related]

  • 25. Self and non-self peptides treat autoimmune encephalomyelitis: T cell anergy or competition for major histocompatibility complex class II binding?
    Gautam AM.
    Eur J Immunol; 1995 Jul 25; 25(7):2059-63. PubMed ID: 7542603
    [Abstract] [Full Text] [Related]

  • 26. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
    Offner H, Adlard K, Bebo BF, Schuster J, Burrows GG, Buenafe AC, Vandenbark AA.
    J Immunol; 1998 Sep 01; 161(5):2178-86. PubMed ID: 9725209
    [Abstract] [Full Text] [Related]

  • 27. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R, de Graaf KL, Storch MK, Barth S, Linington C, Lassmann H, Olsson T.
    J Immunol; 2001 Jun 15; 166(12):7588-99. PubMed ID: 11390515
    [Abstract] [Full Text] [Related]

  • 28. A TCR V alpha CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones.
    Buenafe AC, Tsu RC, Bebo B, Bakke AC, Vandenbark AA, Offner H.
    J Immunol; 1997 Jun 01; 158(11):5472-83. PubMed ID: 9164970
    [Abstract] [Full Text] [Related]

  • 29. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
    Stepaniak JA, Gould KE, Sun D, Swanborg RH.
    J Immunol; 1995 Sep 01; 155(5):2762-9. PubMed ID: 7544385
    [Abstract] [Full Text] [Related]

  • 30. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
    Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R.
    J Immunol; 1994 Oct 01; 153(7):3337-44. PubMed ID: 7522259
    [Abstract] [Full Text] [Related]

  • 31. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
    Mannie MD, Paterson PY, U'Prichard DC, Flouret G.
    J Immunol; 1989 Apr 15; 142(8):2608-16. PubMed ID: 2467932
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
    Zamvil SS, Mitchell DJ, Moore AC, Schwarz AJ, Stiefel W, Nelson PA, Rothbard JB, Steinman L.
    J Immunol; 1987 Aug 15; 139(4):1075-9. PubMed ID: 2440944
    [Abstract] [Full Text] [Related]

  • 35. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
    Bischof F, Wienhold W, Wirblich C, Malcherek G, Zevering O, Kruisbeek AM, Melms A.
    Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):12168-73. PubMed ID: 11593032
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH.
    Mason K, Denney DW, McConnell HM.
    J Immunol; 1995 May 15; 154(10):5216-27. PubMed ID: 7537302
    [Abstract] [Full Text] [Related]

  • 39. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
    de Haan EC, Moret EE, Wagenaar-Hilbers JP, Liskamp RM, Wauben MH.
    Mol Immunol; 2005 Feb 15; 42(3):365-73. PubMed ID: 15589325
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.